Updated:
LINGDU Capital
LingDu Capital is an investment banking firm focused on the Asian market. It has made 23 investments, including a Series A investment in Yijian Health on June...
LINGDU Capital
LingDu Capital is an investment banking firm focused on the Asian market. It has made 23 investments, including a Series A investment in Yijian Health on June 08, 2025.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Asia
Country
China
City
Wuhan
Corporate office
Wuhan, China
Frequently asked questions
What investment strategies does LINGDU Capital pursue?
LINGDU Capital operates across venture capital, growth equity, buyouts, and restructuring mandates. The venture practice spans seed and early-stage investments, while the buyout and restructuring arms target control positions in more mature businesses. This multi-strategy approach is uncommon among smaller Chinese private equity firms, most of which specialize in a single stage.
Where does LINGDU Capital invest geographically?
The firm's investments are concentrated in mainland China, consistent with its headquarters in Wuhan, Hubei province. There is no public evidence of cross-border investment activity, offshore fund structures, or dollar-denominated vehicles in available records.
Who founded LINGDU Capital and how is the firm managed?
Principal names and management structure have not been publicly disclosed as of the latest available information. The firm does not maintain a public-facing team page, and no named investment professionals appear in mainstream financial media tied to the LINGDU Capital entity.
What is the firm's current assets under management?
LINGDU Capital has not publicly disclosed its AUM in any regulatory filing, media report, or voluntary investor communication. Without a disclosed number, the firm's capital base cannot be verified through public record.
Is LINGDU Capital managing institutional third-party capital or proprietary family capital?
LINGDU Capital is classified as an asset manager rather than a family office, which implies external limited partner capital. However, the specific LP base—whether institutional, high-net-worth, or government-linked—has not been disclosed publicly, and no fund closing announcements have been identified that would clarify the investor composition.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: